Werfen announced that Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand — Werfen. As part of this effort, the company has completed organizational transitions and adopted a new global brand identity, including a new corporate logo.
While IL, Inova and Biokit have been part of Werfen since 1992, 2009, and 1973, respectively, they will now be known simply as Werfen. The company has been known as Werfen outside of North America since 2014.
"By sharing one global identity, with the same vision and strategic objectives, our teams around the world will maximize collaboration to set new standards for products and services in hemostasis, acute care, autoimmunity and OEM diagnostics," said Carlos Pascual, CEO at Werfen.
The strategic hubs for the company's key business lines will now be led by chief operating officers and operate as Werfen headquarters and technology centers. These include hemostasis and acute care diagnostics in Bedford, MA, USA; autoimmunity in San Diego, CA, and original equipment manufacturing (OEM) in Barcelona, Spain. Additional technology centers are based in Orangeburg, NY; San Diego, CA; and Munich, Germany.
Werfen has direct commercial operations in more than 30 countries and 5,500 employees.
